Clopidogrel

K K Jain MD (Dr. Jain is a consultant in neurology and has no relevant financial relationships to disclose.)
Originally released August 19, 2003; last updated August 7, 2016; expires August 7, 2019

Historical note and terminology

Platelets are recognized to play a key role in the development of ischemic complications in the arterial circulation, and antiplatelet therapy has proven effective in the treatment and prevention of ischemic events. Aspirin was the first antiplatelet agent to become the gold standard in clinical practice. Clopidogrel was developed as a safer and more effective alternative to aspirin for the prevention and treatment of cerebral and cardiovascular ischemic events.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.